Inventor · Silver Spring, MD, US

Drew M. Pardoll

53Patents
21h-index
76Co-inventors
91Inventor score

Filing activity: Jan 22, 1993 → Sep 26, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US5637483A Irradiated tumor cell vaccine engineered to express GM-CSF Chemistry; Metallurgy 81 Expired
US6268411A Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses Chemistry; Metallurgy 64 Expired
US5861159A Controlled release of pharmaceutically active substances for immunotherapy Emerging Cross-Sectional Technologies 63 Expired
US5633234A Lysosomal targeting of immunogens Emerging Cross-Sectional Technologies 61 Expired
US5904920A Regulation of systemic immune responses utilizing cytokines and antigens Chemistry; Metallurgy 58 Expired
US9132281B2 Focused radiation for augmenting immune-based therapies against neoplasms Human Necessities 56 Active
US7767202B2 Modulation of systemic immune responses by transplantation of hematopoietic stem cells transduced with genes encoding antigens and antigen presenting cell regulatory molecules Emerging Cross-Sectional Technologies 44 Expired
US6193970A Controlled release of pharmaceutically active substances for immunotherapy Emerging Cross-Sectional Technologies 43 Expired
US6350445B1 Method of treating cancer with a tumor cell line having modified cytokine expression Chemistry; Metallurgy 40 Expired
US6033674A Method of treating cancer with a tumor cell line having modified cytokine expression Chemistry; Metallurgy 40 Expired
US7638122B2 Stat3 antagonists and their use as vaccines against cancer Chemistry; Metallurgy 38 Expired
US9005629B2 Method for treating cancer with an antibody to CD223 protein Emerging Cross-Sectional Technologies 38 Active
US5985290A Purified pancreatic tumor cell lines and related compositions and method Chemistry; Metallurgy 36 Expired
US7560540B2 Nucleic acid encoding dendritic cell co-stimulatory molecules Chemistry; Metallurgy 35 Expired
US8551481B2 Anti-cancer vaccine composition comprising an anti-CD223 antibody and kit comprising an anti-cancer vaccine and an anti-CD223 antibody Emerging Cross-Sectional Technologies 34 Active
US7030219B2 B7-DC, Dendritic cell co-stimulatory molecules Chemistry; Metallurgy 34 Expired
US6187306A Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same Human Necessities 31 Expired
US9770467B2 Compositions and methods for cancer immunotherapy Chemistry; Metallurgy 29 Active
US8053558B2 Dendritic cell co-stimulatory molecules Chemistry; Metallurgy 26 Active
US8053414B2 Methods of using B7-DC molecules to induce or enhance an immune response Chemistry; Metallurgy 25 Active
US6734013B2 Use of multivalent chimeric peptide-loaded, MHC/Ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses Chemistry; Metallurgy 21 Expired
US9308253B2 Cancer immunotherapy Human Necessities 18 Active
US10934356B2 Checkpoint blockade and microsatellite instability Chemistry; Metallurgy 10 Active
US11339219B2 Checkpoint blockade and microsatellite instability Chemistry; Metallurgy 5 Active
US11325974B2 Checkpoint blockade and microsatellite instability Chemistry; Metallurgy 5 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.